188 related articles for article (PubMed ID: 23377992)
21. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
[TBL] [Abstract][Full Text] [Related]
22. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
23. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Tokuda Y; Matsushima D; Stein GH; Miyagi S
Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
[TBL] [Abstract][Full Text] [Related]
24. Short-course intrapleural alteplase and DNase in complex effusion with bleeding risk.
Cheong XK; Yu-Lin Ban A; Abdul Hamid MF
Respirol Case Rep; 2020 Oct; 8(7):e00648. PubMed ID: 32864139
[TBL] [Abstract][Full Text] [Related]
25. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
26. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
[TBL] [Abstract][Full Text] [Related]
27. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
Gilbert CR; Gorden JA
Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
[TBL] [Abstract][Full Text] [Related]
28. Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.
Idell S; Florova G; Shetty S; Tucker T; Idell R; Koenig K; Azghani A; Rahman NM; Komissarov A
Clin Pulm Med; 2017 Jul; 24(4):163-169. PubMed ID: 29081644
[TBL] [Abstract][Full Text] [Related]
29. Management of complicated parapneumonic effusions.
Sultan S; Gupta E; Benzaquen S
Curr Opin Pulm Med; 2023 Jan; 29(1):54-59. PubMed ID: 36384805
[TBL] [Abstract][Full Text] [Related]
30. From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.
Karandashova S; Florova G; Idell S; Komissarov AA
Front Pharmacol; 2021; 12():806393. PubMed ID: 35126140
[TBL] [Abstract][Full Text] [Related]
31. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
32. [Intrapleural urokinase in the treatment of parapneumonic effusions].
Mencía Bartolomé S; Escudero Rodríguez N; Téllez González C; Moralo García S; Bastida Sánchez E; Torres Tortosa P
An Pediatr (Barc); 2005 May; 62(5):427-32. PubMed ID: 15871824
[TBL] [Abstract][Full Text] [Related]
33. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas.
Laisaar T; Püttsepp E; Laisaar V
Thorac Cardiovasc Surg; 1996 Oct; 44(5):252-6. PubMed ID: 8948554
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of intrapleural fibrinolytic therapy and dosing strategies used for complicated pleural effusions.
Baumgartner L; Huang E; Sherman D
Pulm Pharmacol Ther; 2022 Oct; 76():102146. PubMed ID: 35868601
[TBL] [Abstract][Full Text] [Related]
35. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
Sahn SA
Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
[TBL] [Abstract][Full Text] [Related]
36. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
Florova G; Azghani AO; Karandashova S; Schaefer C; Yarovoi SV; Declerck PJ; Cines DB; Idell S; Komissarov AA
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L54-L68. PubMed ID: 28860148
[TBL] [Abstract][Full Text] [Related]
37. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
Chin NK; Lim TK
Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
[TBL] [Abstract][Full Text] [Related]
38. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN
Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739
[TBL] [Abstract][Full Text] [Related]
39. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
[No Abstract] [Full Text] [Related]
40. Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report.
Nikoomanesh K; Phan AT; Sond V; Hasan M
Cureus; 2022 Apr; 14(4):e24373. PubMed ID: 35619869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
